Skip to main content
Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.
Published Web Location
http://europepmc.org/articles/PMC4392898?pdf=renderNo data is associated with this publication.
Abstract
Type 2 diabetes (T2D) is a metabolic disease affecting >370 million people worldwide. It is characterized by obesity-induced insulin resistance, and growing evidence has indicated that this causative link between obesity and insulin resistance is associate
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.